Assertio Holdings (ASRT) Other Non Operating Income (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Other Non Operating Income came in at -$35000.0 in Q1 2026, down 94.44% year-on-year from -$630000.0 in Q1 2025, and down 120.71% quarter-over-quarter from $169000.0 in Q4 2025.
Assertio Holdings (ASRT) Other Non Operating Income (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Other Non Operating Income across 8 years of filings, most recently posting -$35000.0 for Q1 2026.
- Other Non Operating Income for Q1 2026 came in at -$35000.0, down 94.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $166000.0 (down 93.95% YoY), and the FY2025 annual result was $180000.0, down 93.49% from the prior year.
- Other Non Operating Income came in at -$35000.0 for Q1 2026 at Assertio Holdings, down from $169000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $2.7 million in Q4 2024 to a low of -$731000.0 in Q4 2022.
- The 5-year median for Other Non Operating Income is $8000.0 (2024), against an average of $204117.6.
- Across the five-year window, Other Non Operating Income tumbled 23450.0% in 2023 and soared 453.78% in 2024, its largest moves.
- Assertio Holdings' Other Non Operating Income stood at -$731000.0 in 2022, then surged by 166.89% to $489000.0 in 2023, then jumped by 453.78% to $2.7 million in 2024, then sank by 93.76% to $169000.0 in 2025, then slumped by 120.71% to -$35000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$35000.0 (Q1 2026), $169000.0 (Q4 2025), and $26000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Assertio Holdings | 151.10 Mn | 79.53 Mn | 7.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35,000.00 |
| Dec 31, 2025 | 169,000.00 |
| Sep 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | -18,000.00 |
| Dec 31, 2024 | 2.71 Mn |
| Sep 30, 2024 | 45,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 489,000.00 |
| Sep 30, 2023 | -467,000.00 |
| Jun 30, 2023 | 11,000.00 |
| Mar 31, 2023 | 802,000.00 |
| Dec 31, 2022 | -731,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | -95,000.00 |
| Mar 31, 2022 | 545,000.00 |
| Dec 31, 2021 | -504,000.00 |
| Sep 30, 2021 | 344,000.00 |
| Jun 30, 2021 | 137,000.00 |